Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT

Clinical trial NCT04173533 · COMPLETED

Trial details

NCT number: NCT04173533
Sponsor: University of Birmingham
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplasia

Start date: 2019-06-14
Primary completion: 2026-04-29
Enrollment: 326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.